Project Grant HT94252510958
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $599K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,200,000 Project Grant to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The award, with an effective date of Sep 30, 2023 and ultimate completion date of Sep 29, 2026, will fund research focused on "Prevention and Treatment of Frostbite Infection with Antimicrobial Pharmacokinetic Analysis" to be conducted at the University's...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,225,783.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to develop a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. The award period runs from Sep 1, 2025 to Aug 31, 2028. The University of Colorado-Denver, a...
- This $428,220 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Colorado-Denver to provide "Innovative Insights into Pulmonary Hypertension Progression: Unraveling the Role of Localized Small Extracellular Vesicles." The research, conducted from December 1, 2024 through November 30, 2026, aims to advance the scientific understanding of pulmonary hypertension and...
- This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $780,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to support research on "An Unconventional Pathway to Melanoma Development and Prevention". The research aims to investigate innovative approaches to address melanoma, a serious form of skin cancer, with the goal of improving...
- This Project Grant award of $577,680.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Colorado to target EHMT1/2 in order to overcome therapy-resistant ovarian cancer. The project will run from May 1, 2025 to April 30, 2029. As a prominent public research university, the University of Colorado has a robust portfolio of federal contract and grant awards across multiple scientific and technological...
- The federal Project Grant award of $2,271,024.00 was provided by the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program, to the University of Colorado-Denver. The award, effective November 1, 2024, supports a four-year research project to improve understanding of next-generation immunotherapy responses in metastatic uveal melanoma. The University of Colorado-Denver, a major public research university with a strong focus on medical...
- The federal Project Grant award for "TARGETING EHMT1/2 TO OVERCOME THERAPY-RESISTANT OVARIAN CANCER" was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,260,839 award, which commenced on May 1, 2025 and is scheduled for completion by April 30, 2029, supports advanced biomedical research to develop innovative medical solutions that address critical health challenges for military personnel and the broader public. The...
- The University of Colorado-Denver has been awarded a $1,130,984 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "DEFINING AND TARGETING CHROMOBOX2 (CBX2)-MEDIATED CHEMORESISTANCE IN HIGH GRADE SEROUS CARCINOMA". The grant will support the university's research efforts to investigate novel approaches for overcoming chemoresistance in high-grade serous carcinoma, a form of ovarian cancer, over a...
- The U.S. Defense Health Agency has awarded a $499,998 Project Grant to the University of Colorado-Denver under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, is for developing a preservation method for vascularized composite allotransplantation (VCA) during static cold storage. This research aims to transform healthcare for military service members and the broader public by...